Pyridyl substituted heterocycles useful for treating or preventing HCV infection
The present invention relates to pyridyl substituted heterocycles and hydro isomers thereof and pharmaceutical compositions thereof that inhibit replication and/or proliferation of HCV virus. The present invention also relates to the use of the pyridyl heterocycles and hydro isomers thereof and/or pharmaceutical compositions comprising the compounds to treat or prevent HCV infections.
1. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
2. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
3. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
4. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
5. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
6. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
7. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
8. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
9. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
10. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
11. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
12. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
13. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
14. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
15. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
16. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
17. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
18. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
19. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
20. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
21. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
22. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
23. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
24. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
25. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
26. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.
27. A compound of the following structural formula:
or a pharmaceutically acceptable salt thereof.